Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Titin Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5100211
Description
Antibody detects endogenous levels of total TITIN.
Monoclonal Anti-Titin can be used for study of the elastic filaments within sarcomeric structures. It is also useful as a differentiation marker in the separation of rhabdomyosarcomas from other muscle tumors. By indirect immunofluorescence the antibody displays a typical striated staining pattern on frozen sections of chicken skeletal and cardiac muscle tissues. Stains the region of the A-I junction by indirect immunofluorescence. It shows a decoration line 0.05 mm from the end of the A band in electron micro-graphs. In immunoblotting using total extracts of chicken breast muscle the antibody reacts specifically with both bands of the titin doublet, and showed no reaction with nebulin.
Specifications
Titin | |
Polyclonal | |
Unconjugated | |
TTN | |
1100001C23Rik; 2.7.11.1; 2310036G12Rik; 2310057K23Rik; 2310074I15Rik; AF006999; AV006427; CMD1G; CMH9; CMPD4; Connectin; connectin/titin; D330041I19Rik; D830007G01Rik; DKFZp451N061; EOMFC; FLJ26020; FLJ26409; FLJ32040; FLJ34413; FLJ39564; FLJ43066; HMERF; L56; LGMD2J; mdm; MYLK5; rhabdomyosarcoma antigen MU-RMS-40.14; shru; structural muscle protein titin; titin; titin protein homolog; titin sequence3; TMD; TTN | |
Rabbit | |
Affinity chromatography | |
RUO | |
22138, 7273, 84015 | |
-20°C | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
A2ASS6, Q8WZ42 | |
TTN | |
A synthesized peptide derived from human TTN(Accession Q8WZ42), corresponding to amino acid residues N2664-K2714. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction